Augmentation of differentiation signals of AML cells by radotinib, as evidenced by the increasing proportion of CD11b+ cells, was associated with the inhibition of LYN kinase activity in NB4 cells. This evidence concerns the gene ITGAM and acute myeloid leukemia.